retatrutide 1 month results Achieves Up to 30.3% Average Weight Loss in Phase 3 TRIUMPH-1 Trial Retatrutide Diet: 40 Meals for

GLP-1 receptor agonists enhance insulin secretion when blood glucose levels are elevated, suppress glucagon release (which normally raises blood sugar), and slow gastric emptying

Cannabinoid receptors in the bed nucleus of the stria terminalis control cortical excitation of midbrain dopamine cells in vivo

Exercise and injection site selection Exercise increases blood flow to working muscles and surrounding tissue

For now, semaglutide is the practical option, while Retatrutide may become an alternative once larger trials confirm its safety and effectiveness

Complementing its insulinotropic effects, GLP-1 also suppresses the release of glucagon, slows gastric emptying and intestinal motility, and induces feelings of satiety 5